MedTrace Logo

Evaluation of the CloSys Closure System as an Adjunct to Standard Compression

NCT00963690 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-01-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of the CloSys Hemostatic Device designed to stop bleeding after an interventional procedure.

Conditions

  • Sealing the Arteriotomy

Interventions

DEVICE

CloSys Hemostatic Device (HD)

Deploy CloSys HD to achieve hemostasis

PROCEDURE

Standard compression

Use standard compression to achieve hemostasis

Sponsors & Collaborators

  • Eminence Clinical Research, Inc.

    collaborator INDUSTRY

  • CloSys Corporation

    lead INDUSTRY

Principal Investigators

  • George Adams, MD · Rex Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2013-04-30
Completion
2013-05-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00963690 on ClinicalTrials.gov